Clinical Guidelines

As part of phase 1 of the Trump administration’s guidelines for re-opening America, CMS issued guidance on providing essential non-COVID-19 care to patients without symptoms of COVID-19 in regions with a low and stable incidence of COVID-19.

The American Academy of Orthopaedic Surgeons has released updates to its glenohumeral joint osteoarthritis clinical practice guidelines, including new trends, evidence and treatment recommendations.

Acute and chronic complications of sickle cell disease necessitate frequent interaction with the medical system.

UCLA Jonsson Comprehensive Cancer Center and UT Southwestern Simmons Comprehensive Cancer Center have become the newest National Comprehensive Cancer Network member institutions.

Approximately 35% of relevant industry payments to U.S.-based authors of American College of Rheumatology clinical practice guidelines remain undisclosed, according to findings published in Arthritis & Rheumatology.

The American College of Gastroenterology has issued new clinical guidelines for the diagnosis and treatment of patients with chronic pancreatitis.

The 2017 American College of Cardiology/American Heart Association BP guideline identified more patients with isolated diastolic hypertension compared with the 2003 Joint National Committee guideline, according to a study published in JAMA.

The American College of Rheumatology, in partnership with the Arthritis Foundation, has released an update to its Guideline for the Management of Osteoarthritis of the Hand, Hip and Knee, for the first time adding provisions that include direct patient participation, according to a press release.

Occupational exposure to carcinogens often is overshadowed by smoking as a risk factor for lung cancer, yet it has been linked to an estimated 30% of lung cancers. Moreover, those who experience this exposure, including first responders, frequently are missed by lung cancer screening guidelines from the U.S. Preventive Services Task Force.

Editor’s Note: The following is a response written by the EXCEL trial leadership to claims of improper conduct of the trial, as outlined in a Healio article posted on Dec. 12, 2019. The EXCEL trial leadership response was issued on Dec. 12. Healio is posting the response in its entirety at the request of the authors.